A Clinical Trial to Investigate the Pharmacokinetic Drug Interaction Between YHR1705 and YHR1706
Status:
Completed
Trial end date:
2017-09-19
Target enrollment:
Participant gender:
Summary
This is a phase 1, open label, multiple-dose, crossover clinical trial to investigate the
pharmacokinetic drug interaction between YHR1705 and YHR1706 in healty male volunteers